Page last updated: 2024-12-11

cellobionic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

cellobionic acid: RN given refers to (beta-D-glucopyranosyl cpd) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

cellobionic acid : A disaccharide consisting beta-D-glucosyl and D-gluconic acid residues joined by a (1->4)-linkage. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6452827
CHEBI ID77021
SCHEMBL ID9322922
MeSH IDM0049794

Synonyms (17)

Synonym
maltobionate
(2r,3r,4r,5r)-2,3,5,6-tetrahydroxy-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexanoic acid
gluconic acid, 4-o-beta-d-gluconic acid
534-41-8
cellobionic acid
4-o-beta-d-glucopyranosyl d-gluconic acid
beta-d-glucopyranosyl-(1->4)-d-gluconic acid
CHEBI:77021
4-o-beta-d-glucopyranosyl-d-gluconic acid
4-o-beta-d-glucosyl-d-gluconic acid
beta-d-glucosyl-(1->4)-d-gluconic acid
maltobionic acid
JYTUSYBCFIZPBE-ZNLUKOTNSA-N
C20888
SCHEMBL9322922
DTXSID70201562
Q27146552

Research Excerpts

Actions

ExcerptReferenceRelevance
"Cellobionic acid doesn't inhibit cellulose degradation enzymes and so its inclusion would increase lignocellulosic degradation efficiency."( Isobutanol production from cellobionic acid in Escherichia coli.
Atsumi, S; Desai, SH; Fan, Z; Rabinovitch-Deere, CA, 2015
)
1.44
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
disaccharideA compound in which two monosaccharides are joined by a glycosidic bond.
carbohydrate acid
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (20)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (10.00)18.7374
1990's1 (5.00)18.2507
2000's1 (5.00)29.6817
2010's9 (45.00)24.3611
2020's7 (35.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.29

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.29 (24.57)
Research Supply Index3.09 (2.92)
Research Growth Index5.79 (4.65)
Search Engine Demand Index21.17 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.29)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (4.76%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (95.24%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]